<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; tools</title>
	<atom:link href="http://www.tapanray.in/tag/tools/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>&#8216;Indian Pharma’s Apathy Towards Digital Marketing’ &#8211; A Misgiving Or Real?</title>
		<link>http://www.tapanray.in/indian-pharmas-apathy-towards-digital-marketing-a-misgiving-or-real/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=indian-pharmas-apathy-towards-digital-marketing-a-misgiving-or-real</link>
		<comments>http://www.tapanray.in/indian-pharmas-apathy-towards-digital-marketing-a-misgiving-or-real/#comments</comments>
		<pubDate>Fri, 02 Jun 2023 06:18:14 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[analytics]]></category>
		<category><![CDATA[apathy]]></category>
		<category><![CDATA[companies]]></category>
		<category><![CDATA[digital]]></category>
		<category><![CDATA[Drug]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[industry]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[misgiving]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[REAL]]></category>
		<category><![CDATA[reality]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[tools]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=10794</guid>
		<description><![CDATA[As I gather from different sources, an increasing number of Indian pharma companies are increasingly embracing digitalization in their marketing operations, especially after the crippling experience during the Covid lockdown period. They realize the use of digital platforms would be a great &#8230; <a href="http://www.tapanray.in/indian-pharmas-apathy-towards-digital-marketing-a-misgiving-or-real/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/indian-pharmas-apathy-towards-digital-marketing-a-misgiving-or-real/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>More Challenges For Brand Launch Success In The New Normal</title>
		<link>http://www.tapanray.in/more-challenges-for-brand-launch-success-in-the-new-normal/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=more-challenges-for-brand-launch-success-in-the-new-normal</link>
		<comments>http://www.tapanray.in/more-challenges-for-brand-launch-success-in-the-new-normal/#comments</comments>
		<pubDate>Mon, 08 Feb 2021 00:00:30 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Challenges]]></category>
		<category><![CDATA[creation]]></category>
		<category><![CDATA[delivery]]></category>
		<category><![CDATA[digital]]></category>
		<category><![CDATA[doctors]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[factors]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[insights]]></category>
		<category><![CDATA[launch]]></category>
		<category><![CDATA[New]]></category>
		<category><![CDATA[normal]]></category>
		<category><![CDATA[Old]]></category>
		<category><![CDATA[orchestrators]]></category>
		<category><![CDATA[outcome]]></category>
		<category><![CDATA[patient-centric]]></category>
		<category><![CDATA[Patients]]></category>
		<category><![CDATA[pivotal]]></category>
		<category><![CDATA[platforms]]></category>
		<category><![CDATA[primary care]]></category>
		<category><![CDATA[products]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[reps]]></category>
		<category><![CDATA[sales]]></category>
		<category><![CDATA[success]]></category>
		<category><![CDATA[supply-chain]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[tools]]></category>
		<category><![CDATA[value]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=10407</guid>
		<description><![CDATA[The drug manufacturers’ life blood to drive business growth has always been successful new product launch. However, this task has always remained a tough challenge to crack, since last so many years for various reasons. According to McKinsey &#38; Company: “About two-thirds of drug &#8230; <a href="http://www.tapanray.in/more-challenges-for-brand-launch-success-in-the-new-normal/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/more-challenges-for-brand-launch-success-in-the-new-normal/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New Digital Tools To Protect From Infection, Neutralize Covid-19</title>
		<link>http://www.tapanray.in/new-digital-tools-to-protect-from-infection-neutralize-covid-19/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=new-digital-tools-to-protect-from-infection-neutralize-covid-19</link>
		<comments>http://www.tapanray.in/new-digital-tools-to-protect-from-infection-neutralize-covid-19/#comments</comments>
		<pubDate>Mon, 03 Aug 2020 00:00:53 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Access]]></category>
		<category><![CDATA[affordable]]></category>
		<category><![CDATA[Availability]]></category>
		<category><![CDATA[care]]></category>
		<category><![CDATA[Coronavirus]]></category>
		<category><![CDATA[COVID-19]]></category>
		<category><![CDATA[Devices]]></category>
		<category><![CDATA[digital]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[infection]]></category>
		<category><![CDATA[initiatives]]></category>
		<category><![CDATA[neutralize]]></category>
		<category><![CDATA[overworked]]></category>
		<category><![CDATA[prevent]]></category>
		<category><![CDATA[protect]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Shycocan]]></category>
		<category><![CDATA[spread]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[tech]]></category>
		<category><![CDATA[technological]]></category>
		<category><![CDATA[tools]]></category>
		<category><![CDATA[transmission]]></category>
		<category><![CDATA[workers]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=10209</guid>
		<description><![CDATA[There seems to be some light at the end of the dark tunnel of a serious biological threat that the world is passing through, since the nightmarish last seven months. The COVID-19 pandemic has spread to 213 countries and territories, and the number &#8230; <a href="http://www.tapanray.in/new-digital-tools-to-protect-from-infection-neutralize-covid-19/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/new-digital-tools-to-protect-from-infection-neutralize-covid-19/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Disruptive Impact of AI on Pharma Sales And Marketing</title>
		<link>http://www.tapanray.in/disruptive-impact-of-ai-on-pharma-sales-and-marketing/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=disruptive-impact-of-ai-on-pharma-sales-and-marketing</link>
		<comments>http://www.tapanray.in/disruptive-impact-of-ai-on-pharma-sales-and-marketing/#comments</comments>
		<pubDate>Mon, 15 Jul 2019 00:00:31 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[applications]]></category>
		<category><![CDATA[Artificial]]></category>
		<category><![CDATA[chain]]></category>
		<category><![CDATA[creative]]></category>
		<category><![CDATA[Disruptive]]></category>
		<category><![CDATA[focus]]></category>
		<category><![CDATA[IMPACT]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Intelligence]]></category>
		<category><![CDATA[KOL]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[Novartis]]></category>
		<category><![CDATA[people]]></category>
		<category><![CDATA[Pfizer]]></category>
		<category><![CDATA[platforms]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[replace]]></category>
		<category><![CDATA[sales]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[technology]]></category>
		<category><![CDATA[tools]]></category>
		<category><![CDATA[transformation]]></category>
		<category><![CDATA[transformative]]></category>
		<category><![CDATA[value]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=9629</guid>
		<description><![CDATA[Artificial Intelligence (AI) that refers to the ability of machines to perform cognitive tasks like thinking, perceiving, learning, problem solving and decision making, is poised to disrupt our world. Initially conceived as a technology that could mimic human intelligence, AI &#8230; <a href="http://www.tapanray.in/disruptive-impact-of-ai-on-pharma-sales-and-marketing/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/disruptive-impact-of-ai-on-pharma-sales-and-marketing/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pharma: Experts’ Handholding is Pivotal in Digital Marketing Transition Phase</title>
		<link>http://www.tapanray.in/pharma-experts-handholding-is-pivotal-in-digital-marketing-transition-phase/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=pharma-experts-handholding-is-pivotal-in-digital-marketing-transition-phase</link>
		<comments>http://www.tapanray.in/pharma-experts-handholding-is-pivotal-in-digital-marketing-transition-phase/#comments</comments>
		<pubDate>Mon, 14 Jan 2019 00:00:28 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[applications]]></category>
		<category><![CDATA[apprehension]]></category>
		<category><![CDATA[apprehensive]]></category>
		<category><![CDATA[apps]]></category>
		<category><![CDATA[commence]]></category>
		<category><![CDATA[digital]]></category>
		<category><![CDATA[Enterprise]]></category>
		<category><![CDATA[ERP]]></category>
		<category><![CDATA[expert]]></category>
		<category><![CDATA[Handholding]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[industry]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[Planning]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Resource]]></category>
		<category><![CDATA[software]]></category>
		<category><![CDATA[start]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[tools]]></category>
		<category><![CDATA[transition]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=9362</guid>
		<description><![CDATA[&#8220;Pilman – A Tapan Ray Website on Helathcare&#8221; completes 10 years, today.  Inspired by some of my dear friends, I created this website on January 14, 2009. Since then, reasonably well-researched articles, penned by me, on various aspects of health &#8230; <a href="http://www.tapanray.in/pharma-experts-handholding-is-pivotal-in-digital-marketing-transition-phase/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/pharma-experts-handholding-is-pivotal-in-digital-marketing-transition-phase/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Indian Pharma To Stay Ahead of The Technology Curve</title>
		<link>http://www.tapanray.in/indian-pharma-to-stay-ahead-of-the-technology-curve/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=indian-pharma-to-stay-ahead-of-the-technology-curve</link>
		<comments>http://www.tapanray.in/indian-pharma-to-stay-ahead-of-the-technology-curve/#comments</comments>
		<pubDate>Mon, 22 May 2017 00:00:23 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Ahead]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[applications]]></category>
		<category><![CDATA[Artificial]]></category>
		<category><![CDATA[Change]]></category>
		<category><![CDATA[Chatbot]]></category>
		<category><![CDATA[curve]]></category>
		<category><![CDATA[digital]]></category>
		<category><![CDATA[generic]]></category>
		<category><![CDATA[humanoids]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Indian]]></category>
		<category><![CDATA[Intelligence]]></category>
		<category><![CDATA[mandatory]]></category>
		<category><![CDATA[Medical]]></category>
		<category><![CDATA[paradigm]]></category>
		<category><![CDATA[patient-centric]]></category>
		<category><![CDATA[platforms]]></category>
		<category><![CDATA[prescription]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[representatitves]]></category>
		<category><![CDATA[shift]]></category>
		<category><![CDATA[staying]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[technology]]></category>
		<category><![CDATA[tools]]></category>
		<category><![CDATA[virtual]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=8236</guid>
		<description><![CDATA[In the ever-changing business environment, many industrial sectors have now started leveraging different cutting-edge technological platforms to improve overall strategic and operational effectiveness, keeping a sharp focus on better stakeholder engagement for greater customer satisfaction. These companies have accepted the &#8230; <a href="http://www.tapanray.in/indian-pharma-to-stay-ahead-of-the-technology-curve/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/indian-pharma-to-stay-ahead-of-the-technology-curve/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pharma Sales Communication: Would ‘Cafeteria Approach’ Be More Productive Today?</title>
		<link>http://www.tapanray.in/pharma-sales-communication-would-cafeteria-approach-be-more-productive-today/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=pharma-sales-communication-would-cafeteria-approach-be-more-productive-today</link>
		<comments>http://www.tapanray.in/pharma-sales-communication-would-cafeteria-approach-be-more-productive-today/#comments</comments>
		<pubDate>Mon, 23 Mar 2015 00:00:11 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[applications]]></category>
		<category><![CDATA[Approach]]></category>
		<category><![CDATA[brand]]></category>
		<category><![CDATA[cafeteria]]></category>
		<category><![CDATA[communication]]></category>
		<category><![CDATA[digital]]></category>
		<category><![CDATA[doctors]]></category>
		<category><![CDATA[e-marketing]]></category>
		<category><![CDATA[effective]]></category>
		<category><![CDATA[force]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[intangible]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[medical representatives]]></category>
		<category><![CDATA[MNC]]></category>
		<category><![CDATA[MR]]></category>
		<category><![CDATA[Pfizer]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[physicians]]></category>
		<category><![CDATA[practitioners]]></category>
		<category><![CDATA[productive]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[rural]]></category>
		<category><![CDATA[sales]]></category>
		<category><![CDATA[SBU]]></category>
		<category><![CDATA[tangible]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[tools]]></category>
		<category><![CDATA[value]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=6465</guid>
		<description><![CDATA[For sales communication, quality of access of pharma Medical Representatives (MRs) to many important and busy doctors has been steadily declining over the past several years, all over the world, and India is no exception. This is mainly because the number of &#8230; <a href="http://www.tapanray.in/pharma-sales-communication-would-cafeteria-approach-be-more-productive-today/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/pharma-sales-communication-would-cafeteria-approach-be-more-productive-today/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Would e-Marketing Replace Medical Representatives?</title>
		<link>http://www.tapanray.in/would-e-marketing-replace-medical-representatives/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=would-e-marketing-replace-medical-representatives</link>
		<comments>http://www.tapanray.in/would-e-marketing-replace-medical-representatives/#comments</comments>
		<pubDate>Mon, 21 Apr 2014 00:00:09 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[AstraZeneca]]></category>
		<category><![CDATA[Boehringer]]></category>
		<category><![CDATA[digital]]></category>
		<category><![CDATA[e-marketing]]></category>
		<category><![CDATA[Eli]]></category>
		<category><![CDATA[GlaxoSmithKline]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Ingelheim]]></category>
		<category><![CDATA[Lilly]]></category>
		<category><![CDATA[Medical]]></category>
		<category><![CDATA[MR]]></category>
		<category><![CDATA[nordisk]]></category>
		<category><![CDATA[Novartis]]></category>
		<category><![CDATA[Novo]]></category>
		<category><![CDATA[Pfizer]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Representatives]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[tools]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=5186</guid>
		<description><![CDATA[Many people within the pharmaceutical industry cannot simply visualize a drug marketing environment without Medical Representatives (MRs) detailing their products to doctors for ever increasing prescription support. This much traditional sales force, for face to face interaction and transaction with the &#8230; <a href="http://www.tapanray.in/would-e-marketing-replace-medical-representatives/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/would-e-marketing-replace-medical-representatives/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>In VUCA World: Changing Dynamics of Prescription Generation Process</title>
		<link>http://www.tapanray.in/in-vuca-world-changing-dynamics-of-prescription-generation-process/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=in-vuca-world-changing-dynamics-of-prescription-generation-process</link>
		<comments>http://www.tapanray.in/in-vuca-world-changing-dynamics-of-prescription-generation-process/#comments</comments>
		<pubDate>Mon, 04 Nov 2013 00:00:41 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[AHJ]]></category>
		<category><![CDATA[American]]></category>
		<category><![CDATA[Challenges]]></category>
		<category><![CDATA[companies]]></category>
		<category><![CDATA[criticality]]></category>
		<category><![CDATA[decision]]></category>
		<category><![CDATA[demand]]></category>
		<category><![CDATA[DES]]></category>
		<category><![CDATA[digital]]></category>
		<category><![CDATA[Drug]]></category>
		<category><![CDATA[e-detailing]]></category>
		<category><![CDATA[effective]]></category>
		<category><![CDATA[eluting]]></category>
		<category><![CDATA[empowerments]]></category>
		<category><![CDATA[frontline]]></category>
		<category><![CDATA[generating]]></category>
		<category><![CDATA[generation process]]></category>
		<category><![CDATA[Heart]]></category>
		<category><![CDATA[human]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[industry]]></category>
		<category><![CDATA[interaction]]></category>
		<category><![CDATA[interfaces]]></category>
		<category><![CDATA[intervention]]></category>
		<category><![CDATA[journal]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[Media]]></category>
		<category><![CDATA[Medical]]></category>
		<category><![CDATA[Mix]]></category>
		<category><![CDATA[MRs]]></category>
		<category><![CDATA[optimal]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[Players]]></category>
		<category><![CDATA[prescription]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Representatives]]></category>
		<category><![CDATA[Social]]></category>
		<category><![CDATA[stent]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[technology]]></category>
		<category><![CDATA[tools]]></category>
		<category><![CDATA[traditional]]></category>
		<category><![CDATA[VUCA]]></category>
		<category><![CDATA[World]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=4051</guid>
		<description><![CDATA[The acronym VUCA is often being used to emphasize upon the Volatility, Uncertainty, Complexity and Ambiguity in various situations. The term has been derived from military vocabulary and is being used since 1990s in the business management parlance. VUCA is also &#8230; <a href="http://www.tapanray.in/in-vuca-world-changing-dynamics-of-prescription-generation-process/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/in-vuca-world-changing-dynamics-of-prescription-generation-process/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
